About
Thomas Gibbs received his bachelor's degree science in applied biology from the University of Wales Institute of Science and Technology, and earned his doctor's degree in philosophy in microbial genetics at the University of Warwick. He has spent more than two decades in the commercialization of life science technologies, split equally between the pharmaceutical industry and scientific tool developers. He has been responsible for a wide range of activities including quality assurance, operations, late-stage product development and marketing, and increasingly business development. He has broad experience in both startups such as Cytion, Covalys, and Med Discovery and more established companies such as Delta Biotechnology, Molecular Devices, and Debiopharm in Europe and the United States of America. He joined Debiopharm International in 2012.
Position in the VCSift Database
- • 5 investors at Debiopharm Innovation Fund are tracked.
- • 672 investors hold the Director role in VCSift. Thomas Gibbs is one of them.
- • 109 investors are based in Switzerland.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Switzerland
Contact Information
Find more investors like Thomas
Search Investors